In the fourth instalment of the COVID-19 Insights series, Professor David Wilkinson, epidemiologist and Deputy Vice Chancellor Engagement, provides us with expert commentary on the latest developments in the pandemic.
David shares data on how nations – including Australia – are coping with managing the COVID-19 pandemic, and reflects on what this means for staff and students at Macquarie.
He delves deep into the world of COVID-19 vaccines, providing analysis on how the rollout is proceeding both here in Australia and internationally.
He also paints a stark picture of the impact of the pandemic on global mortality rates and the battle that is being fought across the world to vaccinate populations, while dealing with COVID-19 variants.
View earlier instalments in the COVID-19 Insights Video Series >>
More Pfizer or Moderna mRNA (95% effective vaccines) should be coming to Australia. Domestic producers should be licensed to make these vaccines. More efforts should be made to produce mRNA vaccines in Australia so we are not dependent on foreign suppliers. We certainly have the skill and resources